Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1995/000001external-prioritypatent/WO1996020706A1/ja
Priority claimed from HU9800558Aexternal-prioritypatent/HUT77739A/hu
Application filed by Torii Pharmaceutical Co LtdfiledCriticalTorii Pharmaceutical Co Ltd
Priority to NO973116ApriorityCriticalpatent/NO973116L/no
Publication of NO973116D0publicationCriticalpatent/NO973116D0/no
Publication of NO973116LpublicationCriticalpatent/NO973116L/no
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Det beskrives et trombolytisk middel som kan bli tilført oralt, der det nevnte middel omfatter 6-amidino-2-naftyl-4-[(4,5-dihydro-1 H-imidazol-2-yl)-amino]benzoat eller et farmasøytisk akseptabelt syreaddisjonssalt av dette.
Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)- etyl]-2,2-difenylacetamidhydroklorid, legemiddel som inneholder forbindelsen, anvendelse av legemidlet til fremstilling av legemiddelpreparater, farmasøytiske preparater som inneholder l